Efficacy of Ultrasound-Guided Needle Knife Release for Trigger Finger
Efficacy of Ultrasound-Guided Tri-Directional Needle Knife Release for Trigger Finger
Mohamed Maher Ismail Ahmed Elashmawy
46 participants
Jan 20, 2025
INTERVENTIONAL
Conditions
Summary
Efficacy of ultrasound-guided tri-directional needle knife release in treating patients with trigger finger. The study evaluates safety, effectiveness, and recovery outcomes of a minimally invasive procedure compared to conventional approaches.
Eligibility
Inclusion Criteria4
- Idiopathic TF at the level of A1 pulley
- Trigger finger of Green's grades II or III or IV (moderate to severe)
- Symptoms persist for at least three months despite conservative treatments.
- Ability to provide informed consent and comply with follow-up requirements.
Exclusion Criteria6
- Patients with secondary causes of TF like diabetes mellitus, rheumatoid arthritis, gout, hypothyroidism, amyloidosis, and sarcoidosis.
- Patients with TF of Green's grade I.
- Previous surgical intervention on the affected digit.
- Allergy or contraindication to local anesthetics.
- Pregnancy or lactation.
- Inability to comply with follow-up assessments.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This procedure involves ultrasound-guided tri-directional needle knife release for the treatment of trigger finger. Local anesthesia using 3-5 ml of 1% lidocaine and 0.25% bupivacaine will be administered for patient comfort. It aims to ensure precise tissue dissection while minimizing risks and improving outcomes. Device: Sonosite M-Turbo Ultrasound Machine with Linear Probe HFL38x (6-13 MHz) is used for real-time imaging during the procedure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06788860